Tygacil Injection, Powder, Lyophilized, For Solution
Product Images NDC 0008-4990

4 FDA label images from Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tygacil (NDC 0008-4990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tygacil 01)

Chemical Structure (Tygacil 01)
Chemical structure of tigecycline, the active ingredient in Tygacil. The diagram shows the molecular arrangement including multiple ring structures and functional groups characteristic of tigecycline.*
FDA Label Image

Logo (Tygacil 01a)

Logo (Tygacil 01a)
The image shows a label for Tygacil (tigecycline) injection, powder, lyophilized for solution 50 mg/5 mL by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The label includes the Pfizer logo and distributor information listing Wyeth Pharmaceuticals in Philadelphia, PA.*
FDA Label Image

Principal Display Panel (50 mg Vial Label)

Principal Display Panel (50 mg Vial Label)
Label for Tygacil (tigecycline) injection, 50 mg per vial, lyophilized powder for intravenous infusion. The label states it is a single-dose vial containing 50 mg tigecycline. It includes directions about the reconstituted solution color, absence of preservatives, and distributor information: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., Philadelphia, PA.*
FDA Label Image

Principal Display Panel (50 mg Vial Carton)

Principal Display Panel (50 mg Vial Carton)
Tygacil 50 mg injection packaging label for tigecycline lyophilized powder for intravenous solution. The label indicates 10 single-dose vials with reconstituted solution requiring further dilution for IV infusion. Manufactured by Wyeth Pharmaceuticals LLC, a Pfizer Inc. subsidiary, with storage and handling instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.